Literature DB >> 27734396

Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Liver Fibrosis.

Li Chen1, David R Brigstock2,3,4.   

Abstract

Hepatic fibrosis is a complex pathology arising from chronic injury. Pathological features are dominated by the excessive production of extracellular matrix proteins, particularly collagens which are deposited as insoluble scar material that can compromise tissue function. Fibrosis in the liver can often be assessed by staining for collagen in tissue sections and this is an approach that is widely used for grading of fibrosis in human biopsies. However, the recognition of the molecular components that drive fibrosis, including CCN proteins, and the involvement of hepatic stellate cells (HSC) as the principal collagen-producing cells in fibrosing liver, has resulted in a wide variety of molecular and cellular approaches to study the pathogenesis of fibrosis both in vivo and in vitro.

Entities:  

Keywords:  Chromatin immunoprecipitation; ELISA; Electrophoretic mobility shift assay; Immunohistochemistry; Immunoprecipitation; In situ hybridization; RT-PCR

Mesh:

Substances:

Year:  2017        PMID: 27734396      PMCID: PMC6032510          DOI: 10.1007/978-1-4939-6430-7_37

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Modeling liver fibrosis in rodents.

Authors:  Christothea Constandinou; Neil Henderson; John P Iredale
Journal:  Methods Mol Med       Date:  2005

2.  Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.

Authors:  Li Chen; Alyssa Charrier; Yu Zhou; Ruju Chen; Bo Yu; Kitty Agarwal; Hidekazu Tsukamoto; L James Lee; Michael E Paulaitis; David R Brigstock
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

Review 3.  Experimental models of hepatic fibrosis: a review.

Authors:  H Tsukamoto; M Matsuoka; S W French
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

4.  Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts.

Authors:  Xiao Liu; Jun Xu; David A Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2013-09

Review 5.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

6.  Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.

Authors:  Sonja Hillebrandt; Claudia Goos; Siegfried Matern; Frank Lammert
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

7.  Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.

Authors:  Li Chen; Alyssa L Charrier; Andrew Leask; Samuel W French; David R Brigstock
Journal:  J Hepatol       Date:  2010-12-13       Impact factor: 25.083

8.  Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1.

Authors:  Li Chen; Ruju Chen; Sherri Kemper; Alyssa Charrier; David R Brigstock
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-30       Impact factor: 4.052

9.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

Authors:  F V Chisari; C A Pinkert; D R Milich; P Filippi; A McLachlan; R D Palmiter; R L Brinster
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

10.  Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.

Authors:  Andrew Leask; Shaoqiong Chen; Daphne Pala; David R Brigstock
Journal:  J Cell Commun Signal       Date:  2008-09-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.